Literature DB >> 11237195

Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis.

A Tokumura1, T Sumida, M Toujima, K Kogure, K Fukuzawa.   

Abstract

Lipid peroxidation is involved in the pathogenesis of chronic diseases including atherosclerosis. Oxidized lipoprotein has diverse biological activities and is believed to initiate atheroma formation and maturate fatty plaque. The active components of oxidized lipoproteins still remain to be clarified, but a likely candidate is the phosphatidylcholine (PC) having an sn-2-short-chain acyl group with a methyl, hydroxyl, aldehydic or carboxylic terminal. These unique PCs, formed by oxidative fragmentation of the polyunsaturated acyl group of the parent PC in liposomes, low density lipoproteins and blood plasma, induce platelet aggregation through the activation of the receptor for platelet-activating factor (PAF), due to their resemblance in structure with PAF. We have found that PAF-like lipids regulate DNA synthesis and production of nitric oxide independently of the activation of the PAF receptor in vascular smooth muscle cells. Regulation of vascular cell function through two distinct signaling pathways mediated by PAF-like lipids provides new insight into the mechanism of induction of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11237195     DOI: 10.1002/biof.5520130106

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  8 in total

Review 1.  Critical insights into cardiovascular disease from basic research on the oxidation of phospholipids: the γ-hydroxyalkenal phospholipid hypothesis.

Authors:  Robert G Salomon; Xiaodong Gu
Journal:  Chem Res Toxicol       Date:  2011-09-30       Impact factor: 3.739

2.  Interaction of Native- and Oxidized-Low-Density Lipoprotein with Human Estrogen Sulfotransferase.

Authors:  Akira Sato; Hinako Watanabe; Miyuki Yamazaki; Eiko Sakurai; Keiichi Ebina
Journal:  Protein J       Date:  2021-03-04       Impact factor: 2.371

3.  Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development.

Authors:  Amir Ravandi; Saeid Babaei; Ramsey Leung; Juan Carlos Monge; George Hoppe; Henry Hoff; Hiroshi Kamido; Arnis Kuksis
Journal:  Lipids       Date:  2004-02       Impact factor: 1.880

Review 4.  Atherosclerosis: integration of its pathogenesis as a self-perpetuating propagating inflammation: a review.

Authors:  Robin N Poston
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-05-15

5.  PC and PE synthesis: mixed micellar analysis of the cholinephosphotransferase and ethanolaminephosphotransferase activities of human choline/ethanolamine phosphotransferase 1 (CEPT1).

Authors:  Marcia M Wright; Christopher R McMaster
Journal:  Lipids       Date:  2002-07       Impact factor: 1.880

Review 6.  Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins.

Authors:  Nans Florens; Catherine Calzada; Egor Lyasko; Laurent Juillard; Christophe O Soulage
Journal:  Toxins (Basel)       Date:  2016-12-16       Impact factor: 4.546

7.  Plasma HDL reduces nonesterified fatty acid hydroperoxides originating from oxidized LDL: a mechanism for its antioxidant ability.

Authors:  Mari Kotosai; Sachiko Shimada; Mai Kanda; Namiko Matsuda; Keiko Sekido; Yoshibumi Shimizu; Akira Tokumura; Toshiyuki Nakamura; Kaeko Murota; Yoshichika Kawai; Junji Terao
Journal:  Lipids       Date:  2013-03-14       Impact factor: 1.880

8.  Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients.

Authors:  Smaragdi Antonopoulou; Alexandros Tsoupras; George Baltas; Helen Kotsifaki; Zacharias Mantzavinos; Constantinos A Demopoulos
Journal:  Mediators Inflamm       Date:  2003-08       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.